{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:20:36Z","timestamp":1774538436859,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008842","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000}}],"reference-count":108,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008842.pub2","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T15:48:31Z","timestamp":1385999311000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunosuppressive T-cell antibody induction for heart transplant recipients"],"prefix":"10.1002","volume":"2013","author":[{"given":"Luit","family":"Penninga","sequence":"first","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian H","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery, RT 2152; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital; Department of Cardiology B; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A","family":"Steinbr\u00fcchel","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery, RT 2152; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"10.1002\/14651858.CD008842.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1111\/tri.1992.5.s1.476","article-title":"Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study","volume":"5 Suppl 1","author":"Balk","year":"1992","journal-title":"Transplantation International"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0022-4804(89)90137-6","article-title":"Comparison of polyclonal antibody sera for early prophylaxis following cardiac transplantation","volume":"47","author":"Bolling","year":"1989","journal-title":"Journal of Surgical Research"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.healun.2006.03.024","article-title":"Ten-year follow-up of a prospective, randomized trial of BT563\/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation","volume":"25","author":"Bonaros","year":"2006","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healun.2007.01.006","article-title":"Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial","volume":"26","author":"Carrier","year":"2007","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD008842.pub2-BIB0006|cit6","first-page":"306","article-title":"Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation","volume":"9","author":"Costanzo-Nordin","year":"1990","journal-title":"Journal of Heart Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.transproceed.2004.02.053","article-title":"Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation","volume":"36","author":"Santo","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.transproceed.2010.06.036","article-title":"Antithymocyte globulin induction therapy in heart transplantation: prospective randomized study of high vs standard dosage","volume":"42","author":"Faggian","year":"2010","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0009|cit9","first-page":"116","article-title":"Anti rejection prophylaxis using ATG-Fresenius S after heart transplantation - long-term clinical results of a prospective, randomised trial","volume":"20","author":"Forni","year":"2007","journal-title":"Transplant International"},{"issue":"26","key":"10.1002\/14651858.CD008842.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa032953","article-title":"Daclizumab to prevent rejection after cardiac transplantation","volume":"352","author":"Hershberger","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0011|cit11","first-page":"2272","article-title":"Preoperative prophylactic OKT3 vs RATG. A randomized clinical study in heart transplant patients","volume":"23","author":"Ippoliti","year":"1991","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0012|cit12","unstructured":"Origlia C Ippoliti G Martinelli L Goggi C Abelli P Negri M A randomized clinical-study of preoperative administration of Okt3 vs Ratg in heart transplanted patients treated with Sandimmun Transplantation and Clinical Immunology 1991 250"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0013|cit13","first-page":"205","article-title":"Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial","volume":"12","author":"Kobashigawa","year":"1993","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD008842.pub2-BIB0014|cit14","first-page":"301","article-title":"Comparative trial of immunoprophylaxis with RATG versus OKT3","volume":"9","author":"Griffith","year":"1990","journal-title":"Journal of Heart Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00007890-199002000-00016","article-title":"Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin","volume":"49","author":"Kormos","year":"1990","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0016|cit16","first-page":"1","article-title":"Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation","volume":"9","author":"Kormos","year":"1990","journal-title":"Journal of Heart Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-199301000-00021","article-title":"A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3","volume":"55","author":"Macdonald","year":"1993","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0018|cit18","unstructured":"Boissonnat P Sebbag L French Heart Nausicaa Study Grp Less infectious deaths with basiliximab (Simulect (R)) over antihymocyte globulin (Thymoglobuline (R)) induction therapy in heart transplantation: Results of nausicaa, a national multicentre prospective randomized study 2005 386"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.healun.2004.11.086","article-title":"Improved safety of basiliximab (Simulect (R)) over antithymocyte globulin (Thymoglobulin (R)) induction therapy in heart transplantation","volume":"24","author":"Mattei","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD008842.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2004.09.010","article-title":"A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation","volume":"24","author":"Mehra","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD008842.pub2-BIB0022|cit22","first-page":"569","article-title":"A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts","volume":"11","author":"Menkis","year":"1992","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0023|cit23","first-page":"143","article-title":"A randomized control trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation","volume":"24","author":"Mullen","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD008842.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1432-2277.2002.tb00171.x","article-title":"A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients","volume":"15","author":"Schnetzler","year":"2002","journal-title":"Transplant International"},{"issue":"11","key":"10.1002\/14651858.CD008842.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.tp.0000209924.00229.e5","article-title":"A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study","volume":"81","author":"Segovia","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0026|cit26","first-page":"201","article-title":"Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor","volume":"2","author":"Wabbijn","year":"2004","journal-title":"Experimental and Clinical Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00007890-199802150-00020","article-title":"Blockade of the interleukin (IL)-2\/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans","volume":"65","author":"Gelder","year":"1998","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007890-199607150-00011","article-title":"A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation","volume":"62","author":"Gelder","year":"1996","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0029|cit29","first-page":"346","article-title":"Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients","volume":"14","author":"Gelder","year":"1995","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0030|cit30","first-page":"450","article-title":"A randomised, double-blind, placebo controlled trial of anti interleukin-2 receptor monoclonal antibody (daclizumab) induction therapy after heart transplantation","volume":"4","author":"Gelder","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"1 Pt 3","key":"10.1002\/14651858.CD008842.pub2-BIB0031|cit31","first-page":"2499","article-title":"Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation","volume":"21","author":"Wollenek","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0041-1345(98)00171-7","article-title":"Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience","volume":"30","author":"Adamson","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1016\/j.transproceed.2005.09.154","article-title":"Influence of induction therapy on rejection and survival in heart transplantation","volume":"37","author":"Almenar","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.healun.2003.12.014","article-title":"Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection","volume":"24","author":"Carlsen","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD008842.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0041-1345(00)01708-5","article-title":"Rabbit antithymocyte globulin induction immunosuppression in heart transplantation","volume":"32","author":"Chien","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.tp.0000168153.50774.30","article-title":"Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab","volume":"80","author":"Chin","year":"2005","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD008842.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.transproceed.2008.07.113","article-title":"Induction immunosuppression with basiliximab in heart transplantation","volume":"40","author":"Chou","year":"2008","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0038|cit38","first-page":"288","article-title":"Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience","volume":"8","author":"Costanzo-Nordin","year":"1989","journal-title":"Journal of Heart Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2003.09.043","article-title":"Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction","volume":"24","author":"Delgado","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD008842.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2006.09.002","article-title":"Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation","volume":"25","author":"Flaman","year":"2006","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0041|cit41","unstructured":"Hegewald MG O'Connell JB Renlund DG Lee HR Burton NA Karwande SV OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation Journal of Heart Transplantation 1989 303 9"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-5223(19)36949-1","article-title":"Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3","volume":"99","author":"Kirklin","year":"1990","journal-title":"Journal of Thorac and Cardiovascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD008842.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.healun.2004.04.014","article-title":"Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)","volume":"24","author":"Koch","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0044|cit44","first-page":"253","article-title":"Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts","volume":"8","author":"Laufer","year":"1989","journal-title":"Journal of Heart Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0045|cit45","first-page":"5","article-title":"Daclizumab in the induction phase of immunosuppression in heart transplant recipients","volume":"10","author":"Petrikovits","year":"2005","journal-title":"Annals of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.healun.2009.11.143","article-title":"A randomized study using humanized monoclonal antibody against Cd52 (Campath-1h) and tacrolimus in heart transplant recipients","volume":"29","author":"Pham","year":"2010","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-198904000-00007","article-title":"A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3","volume":"47","author":"Renlund","year":"1989","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2004.08.003","article-title":"Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation","volume":"24","author":"Rosenberg","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD008842.pub2-BIB0049|cit49","first-page":"III79","article-title":"Prophylactic OKT3 used as induction therapy for heart transplantation","volume":"80","author":"Starnes","year":"1989","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-6143.2009.02856.x","article-title":"Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes","volume":"10","author":"Teuteberg","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1399-0012.2007.00748.x","article-title":"Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study","volume":"22","author":"Yamani","year":"2008","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0052|cit52","unstructured":"Zakliczynski MW Nozynski J Maruszewski M Zembala M Thymoglobuline administered electively early after heart transplantation may protect myocardial hypertrophy (Abstract) American Journal of Transplantation. American Transplant Congress, Seattle [United States] 21-25 May 2005 2005 171"},{"issue":"9","key":"10.1002\/14651858.CD008842.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/00007890-200005150-00026","article-title":"Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines","volume":"69","author":"Zuckermann","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1010-7940(03)00265-3","article-title":"Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation","volume":"24","author":"Zuckermann","year":"2003","journal-title":"European Journal of Cardiothoracic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HCO.0b013e32801466e4","article-title":"Renal protective strategies in heart transplant patients","volume":"22","author":"Cantarovich","year":"2007","journal-title":"Current Opinion in Cardiology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1432-2277.2008.00713.x","article-title":"The long and winding road towards induction of allograft tolerance in the clinic","volume":"21","author":"Chatenoud","year":"2008","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.mot.0000236699.52834.6f","article-title":"Regulatory T-cell subsets and their roles in transplantation tolerance","volume":"11","author":"Chen","year":"2006","journal-title":"Current Opinion in Organ Transplantation"},{"issue":"27","key":"10.1002\/14651858.CD008842.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD008842.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1432-2277.2005.00203.x","article-title":"Incidence and prognosis of cancer following heart transplantation using RATG induction therapy","volume":"18","author":"El-Hamamsy","year":"2005","journal-title":"Transplant International"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.mot.0000186947.23438.3e","article-title":"Calcineurin inhibitor-free immunosuppression after heart transplantation: can chronic side effects be avoided?","volume":"10","author":"Groetzner","year":"2005","journal-title":"Current Opinion in Organ Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.healun.2004.06.009","article-title":"It is time to stop ignoring malignancy in heart transplantation: a call to arms","volume":"24","author":"Hauptman","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2004.01.002","article-title":"To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?","volume":"24","author":"Higgins","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0067|cit67","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0068|cit68","unstructured":"ICH-GCP 1996 International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for Good Clinical Practice. E6 (R1). ICH Harmonised Tripartite Guideline 1996 http:\/\/ichgcp.net"},{"issue":"3","key":"10.1002\/14651858.CD008842.pub2-BIB0069|cit69","first-page":"546","article-title":"Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials","volume":"104","author":"Keus","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008842.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.transproceed.2004.12.135","article-title":"Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids","volume":"37","author":"Kobashigawa","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD008842.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ncpcardio0510","article-title":"Immunosuppression for heart transplantation: where are we now?","volume":"3","author":"Kobashigawa","year":"2006","journal-title":"Nature Clinical Practice Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm1251","article-title":"Organ transplantation--how much of the promise has been realized?","volume":"11","author":"Lechler","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0074|cit74","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0076|cit76","first-page":"77 (abstract 17","article-title":"Development and spectrum of PTLD in 691 cardiac transplant recipients (Htx) receiving induction therapy","volume":"19","author":"Mallinger","year":"1999","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0077|cit77","unstructured":"United States Cochrane Center Master list of journals being searched http:\/\/apps1.jhsph.edu\/cochrane\/masterlist.asp (accessed May 2009)"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.athoracsur.2003.07.007","article-title":"Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results","volume":"77","author":"Mueller","year":"2004","journal-title":"Annals of Thoracic Surgery"},{"issue":"2 SUPPL","key":"10.1002\/14651858.CD008842.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"309S","DOI":"10.1016\/j.transproceed.2004.01.010","article-title":"Immunosuppression for cardiac transplantation - the past, present and future","volume":"36","author":"O'Neill","year":"2004","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0003-4975(01)02645-5","article-title":"Steroid-free maintenance immunosuppression after heart transplantation","volume":"72","author":"Oaks","year":"2001","journal-title":"Annals of Thoracic Surgery"},{"issue":"12","key":"10.1002\/14651858.CD008842.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials","volume":"66","author":"Penninga","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0084|cit84","first-page":"Art. No.: CD008","article-title":"Antibody induction for lung transplant recipients","author":"Penninga","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007341.pub2","article-title":"Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients","author":"Penninga","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008842.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0041-1345(03)00659-6","article-title":"Current induction immunosuppression and post-heart transplant lymphoproliferative disorders","volume":"35","author":"Peraira","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.healun.2004.10.002","article-title":"Long-term calcineurin inhibitor \"holiday\" using daclizumab in a heart transplant patient with acute renal dysfunction","volume":"24","author":"Potter","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0088|cit88","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"5","key":"10.1002\/14651858.CD008842.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1010-7940(01)00674-1","article-title":"Neoplastic disease after heart transplantation: single center experience","volume":"19","author":"Rinaldi","year":"2001","journal-title":"European.Journal of Cardiothoracic Surgery"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7340","article-title":"Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system","volume":"7","author":"Royle","year":"2003","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD008842.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on Intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD008842.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012","volume":"31","author":"Stehlik","year":"2012","journal-title":"Journal of Heart and Lung Transplantation."},{"issue":"6","key":"10.1002\/14651858.CD008842.pub2-BIB0094|cit94","first-page":"619","article-title":"Continuous renal replacement therapy after heart transplantation","volume":"20","author":"Stevens","year":"2004","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"25","key":"10.1002\/14651858.CD008842.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009","volume":"28","author":"Taylor","year":"2009","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"10","key":"10.1002\/14651858.CD008842.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0101|cit101","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for trial sequential analysis (TSA) Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark 2011 1 115"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0102|cit102","unstructured":"Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C Thorlund K Trial Sequential Analysis Programme 2012"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.healun.2007.01.002","article-title":"Induction therapy in heart transplantation: is there a role?","volume":"26","author":"Uber","year":"2007","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008842.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003897.pub3","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","author":"Webster","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Edition)"},{"key":"10.1002\/14651858.CD008842.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2009.02.012","article-title":"Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort","volume":"28","author":"Zuppan","year":"2009","journal-title":"Journal of Heart and Lung Transplantation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008842.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T15:01:21Z","timestamp":1731510081000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008842.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":108,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008842.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}